December 6th, 2013
There are four critical ingredients needed for successful treatment of osteoarthritis with stem cells. Discover what they are in this video.
December 5th, 2013
Treatment with methotrexate for rheumatoid arthritis can cause fatigue.
December 4th, 2013
Methotrexate is commonly is used in rheumatoid arthritis treatment. It can cause nausea. There are a few strategies to try and get around this problem. This video discusses some.
December 3rd, 2013
Pain in the bottom of the heel may signify plantar fasciitis. The treatment for this condition has been improved with more effective treatments such as platelet-rich plasma (PRP, and Botox). Watch now.
December 2nd, 2013
There are multiple risk factors for the development of rheumatoid arthritis. Discover what they are.
November 29th, 2013
Tramadol is an analgesic medicine often used to treat various types of arthritis.
While there might be some concern regarding chronic therapy, it appears to be well tolerated. It needs to be monitored and there are potential drug interactions.
November 28th, 2013
Intra-Articular More Efficacious Than Oral Therapy for Knee Osteoarthritis Pain
Traci Dantoni reporting from the American College of Rheumatology meeting described a study regarding knee osteoarthritis pain. Investigators from Tuft’s University in Boston showed that intra-articular (IA) treatments were more efficacious than oral treatments possibly because of the integrated IA placebo effect.
Comment: The placebo effect can be a tremendous part of the response to injection therapy.
November 27th, 2013
Botox Injection May Treat Arthritis Pain Without Side Effects
Lizette Borelli writing for Medical Daily reported that a ‘super-Botox’ drug could revolutionize chronic pain treatment, possibly making painkillers obsolete. A single injection of the new Botox formula may treat arthritis without the side effects associated with pain medication for months at a time.
Developed by Sheffield University’s Professor Bazbek Davletov at the MRC Laboratory of Molecular Biology in Cambridge, U.K., the new Botox drug is a combination of botulinum — a bacterial poison — and a similar poison — tetanospasmin — produced by the tetanus bug.
Botulinum and tetanospasmin, combined, carry the pain reliever to the spinal cord to stop pain signals from being sent to the brain.
The mix of these two poisons aims to ease fears that the new Botox injection will paralyze the area being treated. With the administration of just Botox, patients fear that the injection will paralyze the area that is being treated, which is why it has been prevented from widely being used for pain relief.
Comment: Wrinkles and arthritis cured with one shot!
November 25th, 2013
Do TNF inhibitors affect hemoglobin A1c levels?
Debra Hughes writing in MPR reported on a study from the United Kingdom. Researchers asked the question, “Do tumor necrosis factor inhibitors (TNFi) improve HbA1c in patients with rheumatoid arthritis?” The answer depends on the agent and on whether patients have diabetes mellitus.
Some disease-modifying anti-rheumatic drugs (DMARDs)—including TNFis—may improve insulin resistance and risk of diabetes mellitus. “However, it is unknown whether TNFis improve HbA1c in patients with rheumatoid arthritis with or without diabetes mellitus,” they stated.
After adjusting for baseline HbA1c among patients without diabetes, those taking Humira had a significant increase in HbA1c levels between baseline and 12 months. In contrast, Enbrel therapy did not influence HbA1c levels over time.
Comment: Patients with RA who have diabetes need to be watched closely.